Leslie C.g. Campbell - 11 Aug 2026 Form 4 Insider Report for PETMED EXPRESS INC (PETS)

Reporting relationship: Interim CEO and President, Director
Issuer ticker: PETS
Reported as of: 11 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Aug 2026, 17:09:41 UTC
Prior SEC filing: 06 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Leslie C.G. Campbell

Key filing fact

Leslie C.g. Campbell filed Form 4 for PETMED EXPRESS INC (PETS) on 13 Aug 2026.

Key facts

This page summarizes Leslie C.g. Campbell's Form 4 filing for PETMED EXPRESS INC (PETS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Aug 2026, 17:09.

Change

Previous filing in this sequence was filed on 06 Dec 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001686078 Primary reporting owner

Campbell Leslie C.G.

Relationship: Interim CEO and President, Director
Address: 420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Signature: /s/ Leslie C.G. Campbell
Signature date: 13 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PETS transaction

Common Stock

Award

Transaction value
Shares: +60,000
Change %: +71%
Price: $0.000000^*
Shares after: 145,000
Date: 11 Aug 2026
Ownership: Direct
Footnotes: F1

PETS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 30,000
Date: 11 Aug 2026
Ownership: By Leslie C.G. Campbell 2020 Irrevocable Trust
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that will vest as to all shares on the first anniversary of the grant date, subject to continued employment and subject to accelerated vesting upon death, disability, a change of control, or certain terminations of employment.

Footnote F2

These shares are held in a trust for the benefit of the family members of the reporting person. The spouse of the reporting person is trustee of the trust, but the reporting person is not a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.